Black and African Americans Connections to Parkinson's Disease (BLAAC PD)

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
Michael J. Fox Foundation for Parkinson's Research
Study ID
NCT06719583
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

BLAAC PD is a research study to understand what Parkinson's disease looks like for Black and African American communities. BLAAC PD is happening at research centers around the United States. The study is part of the Global Parkinson's Genetics Program (GP2). GP2 is a research project working to transform understanding of the genetics of Parkinson's disease and make that knowledge globally relevant.

Key Dates

Start date
Nov 16, 2020
Status verified
Feb 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
2,000 participants (estimated)

Arms

  • Arm: Participants with Parkinson's Disease
    Data collected from these participants include demographic information and family health history. Participants may also complete a physical exam. Participants also complete a smell test and contribute a blood or saliva sample for genetic analyses.
  • Arm: Control Participants
    Data collected from these participants include demographic information and family health history. Participants also complete a smell test and contribute a blood or saliva sample for genetic analyses.

Primary Outcome Measure

Explore novel risk factors and characterization [ Time Frame: 5 years ]

Central Contacts

Locations (12)

FacilityCityStateZIPSite coordinators
University of Alabama at BirminghamBirminghamAlabama35233
Joseph Richardson
205-934-0074
Lauren Ruffrage
205-934-5954
Marissa Dean, MD (PRINCIPAL_INVESTIGATOR)
David Standaert, MD, PhD (SUB_INVESTIGATOR)
University of FloridaGainesvilleFlorida32608
Randy Foli
352-733-2433
Emily Reynolds
352-733-2338
Ashley Rawls, MD (PRINCIPAL_INVESTIGATOR)
Lauren Fanty, MD (SUB_INVESTIGATOR)
Rush UniversityChicagoIllinois60612
Jacqueline Vanegas
312-563-0679
Deborah Hall, MD (PRINCIPAL_INVESTIGATOR)
University of ChicagoChicagoIllinois60637
Hanna Gilluly
773-633-8412
Tao Xie, MD, PhD (PRINCIPAL_INVESTIGATOR)
Mahesh Padmananban, MD (SUB_INVESTIGATOR)
Ochsner Clinic FoundationNew OrleansLouisiana70121
Dominique Thomas
504-842-3980
Julia Staisch, MD (PRINCIPAL_INVESTIGATOR)
Sarah Breaux, MD (SUB_INVESTIGATOR)
Louisiana State University Health Sciences Center ShreveportShreveportLouisiana71103
April Strickland
318-813-3610
Elizabeth Disbrow, PhD (PRINCIPAL_INVESTIGATOR)
University of MarylandBaltimoreMaryland21201
Christina Cooper
410-328-7817
Rebecca Weimer
410 328-1883
Lisa Shulman, MD (PRINCIPAL_INVESTIGATOR)
Rainer von Coelln, MD (SUB_INVESTIGATOR)
Kaiser Permanente Midatlantic StatesRockvilleMaryland20852-
Washington University in St. LouisSt LouisMissouri63119
Coordinator
314-273-5262
Scott Norris, MD (PRINCIPAL_INVESTIGATOR)
Erin Foster, PhD, OTD-L (SUB_INVESTIGATOR)
University Hospitals Cleveland Medical CenterClevelandOhio44106
Ashley Hawkins
216-844-2327
Camilla Kilbane, MD (PRINCIPAL_INVESTIGATOR)
Mohamed Elkasaby, MD (SUB_INVESTIGATOR)
Medical University of South CarolinaCharlestonSouth Carolina29425
Lisa Heidelberg
843-792-6463
Vanessa Hinson, MD (PRINCIPAL_INVESTIGATOR)
Andrew Ameri, MD (SUB_INVESTIGATOR)
University of Texas Health Science Center, HoustonHoustonTexas77030
Natalia Pessoa Rocha
713 500 7496
Erin Furr Stimming, MD (SUB_INVESTIGATOR)
Shivika Chandra, MD (PRINCIPAL_INVESTIGATOR)
Natalia Pessoa Rocha, PhD (SUB_INVESTIGATOR)

Find similar trials in Birmingham, AL

Related Studies